We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$12.1B
AUM Growth
+$5.18B
Cap. Flow
+$5.01B
Cap. Flow %
41.5%
Top 10 Hldgs %
21.6%
Holding
2,250
New
668
Increased
659
Reduced
374
Closed
543

Top Buys

Rank Stock Value
1
EXC icon
Exelon
EXC
+$101M
2
PPL
PPL Corp
PPL
+$72.8M
3
OXY icon
Occidental Petroleum
OXY
+$62.9M
4
DUK icon
Duke Energy
DUK
+$61.4M
5
FDX icon
FedEx
FDX
+$60M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$52.9M
2
APA icon
APA Corp
APA
+$51.1M
3
TTC icon
Toro Company
TTC
+$34.3M
4
CNH
CNH Industrial
CNH
+$32.6M
5
ETR icon
Entergy
ETR
+$30.1M

Sector Composition

Rank Sector Weight
1 Industrials 10.84%
2 Technology 10.75%
3 Healthcare 9.82%
4 Utilities 8.33%
5 Energy 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLT icon
251
Hilton Worldwide
HLT
$73.5B
$11M 0.09%
78,028
+28,247
+57% +$3.98M
RH icon
252
CALL
RH
RH
$2.9B
$10.9M 0.09%
+45,000
New +$13.1M
KRYS icon
253
Krystal Biotech
KRYS
$10.3B
$10.9M 0.09%
136,141
+30,380
+29% +$2.39M
ARE icon
254
Alexandria Real Estate Equities
ARE
$9.21B
$10.9M 0.09%
86,476
+69,648
+414% +$10.2M
XENE icon
255
Xenon Pharmaceuticals
XENE
$5.88B
$10.8M 0.09%
+302,980
New +$11.2M
ADSK icon
256
Autodesk
ADSK
$53.6B
$10.8M 0.09%
51,683
+6,657
+15% +$1.37M
A icon
257
Agilent Technologies
A
$44.9B
$10.7M 0.09%
77,541
+47,553
+159% +$6.95M
LTHM
258
DELISTED
Livent Corporation
LTHM
$10.7M 0.09%
493,335
+332,223
+206% +$7.68M
IR icon
259
Ingersoll Rand
IR
$31.2B
$10.7M 0.09%
183,931
-91,357
-33% -$5.15M
MCD icon
260
McDonald's
MCD
$192B
$10.7M 0.09%
38,152
+14,285
+60% +$3.83M
CMBT
261
CALL
CMB.TECH NV
CMBT
$5.24B
$10.7M 0.09%
+634,700
New +$10.5M
AMZN icon
262
CALL
Amazon
AMZN
$2.79T
$10.6M 0.09%
103,000
+98,200
+2,046% +$9.49M
LOW icon
263
Lowe's Companies
LOW
$121B
$10.6M 0.09%
53,059
-67,745
-56% -$13.8M
K
264
DELISTED
Kellanova
K
$10.5M 0.09%
+167,777
New +$10.6M
ISRG icon
265
Intuitive Surgical
ISRG
$134B
$10.5M 0.09%
41,236
+661
+2% +$163K
TSVT
266
DELISTED
2seventy bio
TSVT
$10.5M 0.09%
1,029,040
+121,905
+13% +$1.39M
NKE icon
267
PUT
Nike
NKE
$60.5B
$10.4M 0.09%
85,300
+81,700
+2,269% +$10M
QCOM icon
268
CALL
Qualcomm
QCOM
$169B
$10.4M 0.09%
81,700
+77,500
+1,845% +$9.64M
ADBE icon
269
CALL
Adobe
ADBE
$109B
$10.4M 0.09%
27,000
+25,800
+2,150% +$9.17M
ADBE icon
270
PUT
Adobe
ADBE
$109B
$10.4M 0.09%
27,000
+25,800
+2,150% +$9.17M
CPB icon
271
Campbell Soup
CPB
$7.14B
$10.4M 0.09%
+188,519
New +$10M
IQV icon
272
IQVIA
IQV
$42.8B
$10.3M 0.09%
51,922
+11,409
+28% +$2.44M
DVN icon
273
CALL
Devon Energy
DVN
$54B
$10.3M 0.09%
+203,600
New +$11.6M
FR icon
274
First Industrial Realty Trust
FR
$8.34B
$10.3M 0.09%
193,231
+66,363
+52% +$3.46M
BCRX icon
275
BioCryst Pharmaceuticals
BCRX
$2.44B
$10.2M 0.08%
1,221,681
+1,199,839
+5,493% +$11.6M
9 10
11
12 13

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q1 2023 Portfolio in Review

As of Q1 2023, Michael Gelband held 2,250 positions worth $12.1B, up 75% from $6.89B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Michael Gelband deployed $5.01B of net new capital in Q1 2023, opening 668 new positions and adding to 659 existing holdings. Its largest new stake was Valero Energy: 333,288 shares worth $46.5M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $52.9M trimmed.

  • Michael Gelband's largest Q1 2023 buy was Valero Energy: 333,288 shares worth $46.5M.
  • Michael Gelband added most to Exelon in Q1 2023, an estimated $101M increase.
  • Michael Gelband's biggest Q1 2023 reduction was Apple, cutting an estimated $52.9M.
  • Michael Gelband fully exited APA Corp in Q1 2023, selling an estimated $51.1M.
  • Michael Gelband's ten largest holdings make up 22% of its $12.1B portfolio in Q1 2023.
  • Michael Gelband opened 668 new positions and closed 543 in Q1 2023.
  • Michael Gelband's portfolio value rose 75% quarter-over-quarter to $12.1B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2023, filed 11 May 2023.